Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses.

Naderi, Nadereh; Rahimzadeh, Mahsa

Naderi, Nadereh; Rahimzadeh, Mahsa.

Afiliação

Naderi N; Infectious and Tropical Diseases Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran; Department of Immunology, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Rahimzadeh M; Infectious and Tropical Diseases Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran; Department of Biochemistry, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran. Electronic address: rahimzadeh91@gmail.com.

Virology ; 566: 106-113, 2022 01.

Article em En | MEDLINE | ID: mdl-34896901

Assuntos

COVID-19/sangue; COVID-19/diagnóstico; Mucina-1/sangue; SARS-CoV-2; Adulto; Idoso; Biomarcadores/sangue; Feminino; Humanos; Masculino; Pessoa de Meia-Idade; Prognóstico; Índice de Gravidade de Doença

Palavras-chave

COVID-19; KL-6; Mucin-1

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD Base de dados: MEDLINE Assunto principal: Mucina-1 / SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Virology Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google